The revised 2021 European AIDS Clinical Society (EACS) Guidelines contain extensive updates, guidance on COVID-19 management, and offer a broader range of preferred choices than US guidelines.
The era of exclusive triple therapy for the treatment of HIV may be coming to an end as evidence mounts in support of the safety and efficacy of new dual-therapy (two-drug) regimens. The era of exclusive triple therapy for the treatment of HIV may be coming to an end as evidence mounts in suppo.
Trials are showing that certain combinations of two antiretrovirals might be as good as three, potentially bringing an end to 25 years of triple therapy dominance.
Cabenuva, the first long-acting injectable drug for HIV treatment, was approved in January and is slowly rolling out to clinics and patients nationwide.